About
Small Molecules
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
2
As Collaborator
2
Total Enrollment
1,073
By Phase
PHASE4: 1PHASE1: 2PHASE3: 1
By Status
COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05310734Lead Sponsor
PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies
PHASE4Recruiting
50 participants
Started: Mar 4, 2022 · Completed: Mar 31, 2026
NCT02307864Collaborator
Study to Evaluate the Effects of Tramadol Hydrochloride on Cardiac Repolarization in Healthy Participants
PHASE1Completed
68 participants
Started: Dec 4, 2014 · Completed: Aug 27, 2015
NCT01947920Collaborator
A Dose Ranging Escalation Study of Tramadol Hydrochloride in Healthy Volunteers
PHASE1Completed
30 participants
Started: Aug 31, 2013 · Completed: Nov 30, 2013
NCT00975143Lead Sponsor
Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne
PHASE3Completed
925 participants
Started: Sep 30, 2009 · Completed: May 31, 2011
Locations (1)
Headquarters
Mississauga, ON, Canada
Map
Loading map...